weight loss drug prescriptions semaglutide tirzepatide q3 2024 Major Increase in Prescribed Drugs Ozempic® & Mounjaro® iqvia weight loss drug prescriptions

Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease

No clinically relevant effect on the rate of gastric emptying was observed with tirzepatide 2.4 mg

Does AHCCCS cover GLP-1 medications

[PMID: 32082707] PubMed record related to this compound for laboratory literature review